Cytomegalovirus by Quantitative NAAT, Plasma
Also known as: CMVQ
Use
This test is used to detect and quantify cytomegalovirus (CMV) in plasma. It is essential for monitoring CMV viral load, especially in immunocompromised patients such as organ transplant recipients, where viral load monitoring can guide therapeutic interventions.
Special Instructions
Not provided.
Limitations
An interpretation of 'Not Detected' does not rule out the presence of inhibitors or CMV DNA concentration below the detection level of the assay. International standardization has improved assay comparability across laboratories, but discrepancies might still exist due to commutability issues with the standard. Assay detects CMV DNA concentrations within 1.54-7.00 log IU/mL (34.5-10,000,000 IU/mL) range.
FDA ApprovedNew York Approved
Methodology
PCR-based (Quantitative Polymerase Chain Reaction)
Biomarkers
LOINC Codes
- 72493-0 - CMV DNA SerPl NAA+probe-aCnc
- 72494-8 - CMV DNA SerPl NAA+probe-Log IU
- 30246-3 - CMV DNA SerPl Ql NAA+probe
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
2 mL
Minimum Volume
1 mL
Container
ARUP standard transport tube, ARUP supply #15824
Collection Instructions
Separate from cells within 24 hours of collection.
Storage Instructions
Transport frozen.
Causes for Rejection
Heparinized specimens, whole blood, serum, respiratory specimens, CSF.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hrs |
| Refrigerated | 6 days |
| Frozen | 12 weeks |
Other tests from different labs that may be relevant